UnipharDUB:UPR -0.65%82 Gross Margin % is 14.98% as of Dec. 2025, which is 15% above its 10-year median of 13.02. GuruFocus rates DUB:UPR with a GF Score™ of 82/100 and a GF Value™ of €3.64 (Modestly Overvalued). The stock has 9 warning signs investors should review. Among 118 Medical Distribution companies, Uniphar ranks worse than 51.69% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Uniphar's Gross Profit for the
six
months ended in Dec. 2025 was €238 Mil. Uniphar's Revenue for the
six
months ended in Dec. 2025 was €1,589 Mil. Therefore, Uniphar's Gross Margin % for the quarter that ended in Dec. 2025 was 14.98%.
The historical rank and industry rank for Uniphar's Gross Margin % or its related term are showing as below:
DUB:UPR'
s Gross Margin % Range Over the Past 10 Years
Min: 6.47 Med: 13.02 Max: 15.43
Current: 14.89
During the past 10 years, the highestGross Margin % of Uniphar was 15.43%. The lowest was 6.47%. And the median was 13.02%.
DUB:UPR's Gross Margin % is ranked worse than 51.69% of 118
companies
in the Medical Distribution industry
Industry Median: 14.975
vs DUB:UPR: 14.89
Uniphar had a gross margin of 14.98% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Uniphar was 4.10% per year.
Uniphar (DUB:UPR) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Uniphar had a gross margin of 14.98% for the quarter that ended in Dec. 2025 => No sustainable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Uniphar Gross Margin % Related Terms
Uniphar Gross Margin % Historical Data
* Premium members only.
The historical data trend for Uniphar's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DUB:UPR vs MCK, COR, CAH: Gross Margin % Comparison
For the Medical Distribution subindustry, Uniphar's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Uniphar Gross Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Uniphar's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Uniphar's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Uniphar (DUB:UPR) has a Gross Margin % of 14.98% as of Dec. 2025. Gross margin is the ratio of total gross profit to net sales. View historical data on Uniphar and its competitors. This is 15% above median its historical median of 13.02. Over the past decade, Uniphar's Gross Margin % has ranged from 6.47 to 15.43. According to the industry distribution chart, Uniphar ranks #61 out of 118 companies in the Medical Distribution industry, placing it in the top 51.7%.
Is Uniphar's Gross Margin % too high?
Uniphar's current Gross Margin % of 14.98% is 15% above median its 10-year median of 13.02. Over the past 10 years, this metric has ranged from a low of 6.47 to a high of 15.43. The Medical Distribution industry median Gross Margin % is 14.98. Uniphar's value of 14.98% is 0% above this industry median. Based on the distribution chart, Uniphar ranks #61 out of 118 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Uniphar has a GF Score™ of 82/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Uniphar's Gross Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, Uniphar ranks #61 out of 118 companies for Gross Margin %. This places Uniphar in the lower half of its industry. The industry median Gross Margin % is 14.98. Uniphar's value of 14.98% is 0% above this benchmark. Historically, Uniphar's own Gross Margin % has ranged from 6.47 to 15.43 over the past decade. While the company's 10-year median is 13.02 vs. the industry median of 14.98, Uniphar has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Distribution company?
The median Gross Margin % among Medical Distribution companies is 14.98, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Uniphar's current Gross Margin % of 14.98% is 0% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Uniphar and its competitors. For the Medical Distribution industry, the median Gross Margin % is 14.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Uniphar's current Gross Margin % is 14.98%, which is 15% above median its own 10-year median of 13.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Uniphar stock overvalued right now?
Based on GuruFocus' analysis, Uniphar (DUB:UPR) is currently considered Modestly Overvalued. The stock's GF Value™ is €3.64, compared to a current price of €4.57 — trading 25.5% above its estimated fair value. The current Gross Margin % is 14.98%, which is 15% above median its 10-year median of 13.02 and 0% above the Medical Distribution industry median of 14.98. Uniphar's overall GF Score™ is 82/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Uniphar (DUB:UPR), the current Gross Margin % is 14.98% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Uniphar (DUB:UPR) Overvalued in 2026?
Based on GuruFocus' analysis, Uniphar stock appears to be overvalued.
The current stock price of €4.57 is trading 25.5% above its estimated GF Value™ of €3.64.
GuruFocus considers Uniphar to be Modestly Overvalued.
Key valuation signals for DUB:UPR:
Gross Margin %: 14.98% (15% above median its 10-year median of 13.02)
GF Value™: €3.64 vs. price of €4.57 (25.5% above fair value)
Industry Position: 0% above the Medical Distribution median (#61 of 118)
No single metric tells the full story. See the DUB:UPR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Uniphar PLC is a service provider within the pharmaceutical and healthcare sector. The company is an international diversified healthcare services business servicing the requirements of multinational pharmaceutical and medical technology manufacturers across three divisions - Uniphar Pharma, Uniphar Medtech and Uniphar Supply Chain & Retail. Uniphar Pharma enables pharma and biotech companies to bring medicines to markets globally and provide healthcare professionals with access to medicines that can't be sourced through traditional channels. Uniphar Medtech is a Pan-European medical device distributor and solutions partner. Uniphar Supply Chain & Retail is the pharmaceutical wholesaler in Ireland offering of retail pharmacies.
82GF Score
Get the complete analysis for DUB:UPR
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
DUB:UPR has been successfully added to your 
